RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Keith Norris to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Back to Details
This is a "connection" page, showing publications Keith Norris has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Keith Norris
Connection Strength
1.035
Hydroxymethylglutaryl-CoA Reductase Inhibitors
  1. Obialo CI, Ofili EO, Norris KC. Statins and Cardiovascular Disease Outcomes in Chronic Kidney Disease: Reaffirmation vs. Repudiation. Int J Environ Res Public Health. 2018 12 04; 15(12).
    View in: PubMed
    Score: 0.621
  2. Vaziri ND, Norris KC. Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations. Blood Purif. 2013; 35(1-3):31-6.
    View in: PubMed
    Score: 0.414
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support